SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-026600
Filing Date
2024-03-27
Accepted
2024-03-27 16:10:33
Documents
15
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202194-8k_avalonglobo.htm   iXBRL 8-K 29668
2 MORTGAGE AND SECURITY AGREEMENT, DATED MARCH 27, 2024, BETWEEN AVALON GLOBOCARE ea020219401ex10-1_avalonglob.htm EX-10.1 158898
3 MORTGAGE AND SECURITY AGREEMENT, DATED MARCH 27, 2024, BETWEEN AVALON GLOBOCARE ea020219401ex10-2_avalonglob.htm EX-10.2 158987
  Complete submission text file 0001213900-24-026600.txt   610479

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE albt-20240327.xsd EX-101.SCH 3039
5 XBRL LABEL FILE albt-20240327_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE albt-20240327_pre.xml EX-101.PRE 22375
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0202194-8k_avalonglobo_htm.xml XML 3615
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 24790719
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)